Results 211 to 220 of about 125,630 (314)

Bleeding Disorders in Children With Genetic Diseases: A Narrative Review

Acta Paediatrica, EarlyView.
ABSTRACT Aim The lack of data on bleeding risk assessment in children with genetic diseases is concerning given their increased care needs and risk of haemorrhagic complications compared to the general population. Identification of haemostatic disorders is crucial for implementing preventive measures and mitigating bleeding risk.
Raphaelle Cagol, Mariam Sbeity Barakat, Marjolaine Willems, Tasnime Akbaraly, Biron‐Andreani Christine, Isabelle Diaz, Alexandre Theron   +6 more
wiley   +1 more source

Comparative Efficacy of Monotherapies for Chronic Hand Eczema: A Network Meta-Analysis Study. [PDF]

J Cosmet Dermatol
Gupta AK, Bamimore MA, Talukder M.
europepmc   +1 more source

Echoes of ease: Tracing the course of obsessive‐compulsive symptoms in the aftermath of a pandemic—Insights from a four‐year panel study

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives The COVID‐19 pandemic affected mental health worldwide, including obsessive‐compulsive symptoms (OCS) and, specifically, contamination‐related OCS (C‐OCS). This study aimed to map these symptoms' trajectories over four years, thus providing the longest known observational timeline of OCS during and after a pandemic.
Lea Schuurmans, Anna Baumeister, Anja S. Göritz, Steffen Moritz, Franziska Miegel, Lena Jelinek   +5 more
wiley   +1 more source

Unravelling the Mystery of Psoriasis Dermatitis (PsoDermatitis): A Practical Guide to Recognition and Management. [PDF]

J Clin Med
Balestri R, Magnano M, Infusino SD, Ioris T, Lacava R, Girardelli CR, Rech G.   +6 more
europepmc   +1 more source

Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC‐2

Clinical &Experimental Allergy, EarlyView.
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz, Thomas Rothe, Lieven Dupont, Trung N. Tran, Andrew Menzies‐Gow, Anat Shavit, David Cohen, Tanja Plate, Sheena Kayaniyil, An Herreman, Claudio Schuoler, Benjamin Emmanuel, Marek Lommatzsch   +12 more
wiley   +1 more source

Identification of hub genes contributing to acute eczema using transcriptome sequencing and machine-learning approaches. [PDF]

BMC Med Genomics
Zhao Y, Wang W, Li X, Ye X, Han X.
europepmc   +1 more source

Atopic eczema [PDF]

BMJ, 1995
openaire   +2 more sources

Hand Eczema, Risk Factors and Microbial Skin Contamination in the Norwegian Waste Sorting Industry: A Cross-Sectional Study. [PDF]

Contact Dermatitis
Alfonso JH, Graff P, Viegas C, Lossius AH, Eriksen E.   +4 more
europepmc   +1 more source

Eczema – Quiz [PDF]

Paediatrics & Child Health, 2000
openaire   +2 more sources